1. Home
  2. HSCS vs MOVE Comparison

HSCS vs MOVE Comparison

Compare HSCS & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSCS
  • MOVE
  • Stock Information
  • Founded
  • HSCS 2007
  • MOVE 2018
  • Country
  • HSCS United States
  • MOVE United States
  • Employees
  • HSCS N/A
  • MOVE N/A
  • Industry
  • HSCS Medical Specialities
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • HSCS Health Care
  • MOVE Health Care
  • Exchange
  • HSCS Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • HSCS 9.9M
  • MOVE 8.9M
  • IPO Year
  • HSCS 2022
  • MOVE 2021
  • Fundamental
  • Price
  • HSCS $2.97
  • MOVE $10.44
  • Analyst Decision
  • HSCS Strong Buy
  • MOVE
  • Analyst Count
  • HSCS 2
  • MOVE 0
  • Target Price
  • HSCS $10.50
  • MOVE N/A
  • AVG Volume (30 Days)
  • HSCS 32.6K
  • MOVE 2.5M
  • Earning Date
  • HSCS 12-15-2025
  • MOVE 11-14-2025
  • Dividend Yield
  • HSCS N/A
  • MOVE N/A
  • EPS Growth
  • HSCS N/A
  • MOVE N/A
  • EPS
  • HSCS N/A
  • MOVE N/A
  • Revenue
  • HSCS $6,250.00
  • MOVE $500,000.00
  • Revenue This Year
  • HSCS N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • HSCS N/A
  • MOVE $96.77
  • P/E Ratio
  • HSCS N/A
  • MOVE N/A
  • Revenue Growth
  • HSCS N/A
  • MOVE N/A
  • 52 Week Low
  • HSCS $2.53
  • MOVE $4.67
  • 52 Week High
  • HSCS $6.47
  • MOVE $69.68
  • Technical
  • Relative Strength Index (RSI)
  • HSCS 44.22
  • MOVE 60.68
  • Support Level
  • HSCS $2.95
  • MOVE $9.49
  • Resistance Level
  • HSCS $3.15
  • MOVE $11.66
  • Average True Range (ATR)
  • HSCS 0.19
  • MOVE 2.04
  • MACD
  • HSCS 0.03
  • MOVE 0.12
  • Stochastic Oscillator
  • HSCS 53.62
  • MOVE 32.88

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: